{
    "clinical_study": {
        "@rank": "47000", 
        "arm_group": [
            {
                "arm_group_label": "GYNEFFIK(R)", 
                "arm_group_type": "Experimental", 
                "description": "30 min-session of vaginal electro-stimulation by GYNEFFIK thrice a week for 6 months (except during menstrual periods)"
            }, 
            {
                "arm_group_label": "Usual Care", 
                "arm_group_type": "Other", 
                "description": "Any treatment / physiotherapy sessions / muscular training ... usually recommended and/or prescribed by the patient's general practitioner or gynaecologist with the exception of vaginal electro-stimulation"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of this study is to assess the benefit of GYNEFFIK\u00ae, a perineal electro-stimulator,\n      during this home-care phase. Women with stress urinary incontinence (UI) or with mixed UI\n      (composed predominantly of stress UI), that responded to physiotherapy were included in this\n      study in two parallel groups. The groups followed a self-reeducation program, with or\n      without GYNEFFIK\u00ae electro-stimulation sessions. The comparison of the two groups was based\n      on the rate of women for whom the benefit of the initial perineal reeducation was\n      maintained."
        }, 
        "brief_title": "Interest of Intravaginal Electro-stimulation at Home by GYNEFFIK\u00ae Compared to Usual Care in Incontinent Patients With Prior Perineal Reeducation", 
        "completion_date": {
            "#text": "February 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Urinary Stress Incontinence", 
            "Urinary Mixed Incontinence"
        ], 
        "condition_browse": {
            "mesh_term": "Urinary Incontinence, Stress"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  out-patient over 18 years old, having understood and signed the Informed Consent Form\n\n          -  seen for urinary stress incontinence or urinary mixed incontinence (with a major\n             stress incontinence part) troubles\n\n          -  spontaneously asking for help\n\n          -  who can be followed for a long time\n\n        Exclusion Criteria:\n\n          -  Urinary Incontinence (UI) found out during medical interviewing without spontaneous\n             complaint\n\n          -  Urinary troubles due to neurological pathology (stroke, multiple sclerosis, ...)\n\n          -  UI due to congenital malformation\n\n          -  UI having led to surgery\n\n          -  UI treated in the last 6 months\n\n          -  UI within 24 weeks of Past Partum\n\n          -  Pelvic surgery within 12 months\n\n          -  On-going inflammatory or infectious neoplastic disease\n\n          -  Perineal hypoesthesia\n\n          -  Local conditions prohibiting the use of an intra-vaginal device (vaginal atrophia,\n             continuous metrorrhagia, vaginal prolapse > 2\u00b0, ...)\n\n          -  Pacemaker use\n\n          -  Women of child bearing potential without effective method of contraception or\n             planning to get pregnant in the next 12 months\n\n          -  Intravaginal contraception\n\n          -  Mental impairment or inability to understand or follow study instructions\n\n          -  Patient who may not come back to the study visits\n\n          -  Patient already enrolled for another study or having been enrolled in another\n             clinical study in the past 3 months"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "163", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "January 6, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02029027", 
            "org_study_id": "2012-A00235-38"
        }, 
        "intervention": [
            {
                "arm_group_label": "GYNEFFIK(R)", 
                "description": "Vaginal electro-stimulation medical device", 
                "intervention_name": "GYNEFFIK(R)", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Usual Care", 
                "description": "Any treatment / physiotherapy sessions / muscular training ... usually recommended and/or prescribed by the patient's general practitioner or gynaecologist with the exception of vaginal electro-stimulation", 
                "intervention_name": "Usual Care", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Urinary Stress Incontinence", 
            "Urinary Mixed Incontinence"
        ], 
        "lastchanged_date": "January 6, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Marseille", 
                    "country": "France", 
                    "zip": "13008"
                }, 
                "name": "Marc Bernardini"
            }
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Evaluation de l'int\u00e9r\u00eat de l'\u00e9lectrostimulation Intra-vaginale \u00e0 Domicile Par Rapport \u00e0 Une Prise en Charge Habituelle Dans la Prise en Charge de Patientes Incontinentes Ayant b\u00e9n\u00e9fici\u00e9 d'Une r\u00e9\u00e9ducation p\u00e9rin\u00e9ale", 
        "other_outcome": [
            {
                "measure": "Adverse Events", 
                "safety_issue": "Yes", 
                "time_frame": "6 Months"
            }, 
            {
                "description": "The lasts electro-stimulation sessions are recorded by the medical device.", 
                "measure": "Compliance", 
                "safety_issue": "No", 
                "time_frame": "6 Months"
            }
        ], 
        "overall_official": {
            "last_name": "Marc Bernardini, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": [
                "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
                "France: Conseil National de l'Ordre des M\u00e9decins"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "February 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The primary outcome is defined as the non worsening of the ICIQ (International Consultation on Incontinence modular Questionnaire) scale's score AND the DITROVIE scale's score (a specific scale to evaluate the perturbation of the quality of life during urinary troubles).\nThe scores will be considered as maintained if they didn't increase more than 10% with the following calculation:\nICIQ variation (%) = 100 x (ICIQ_M6 - ICIQ_D0)/ICIQ_D0\nDITROVIE variation (%) = 100 x (DITROVIE_M6 - DITROVIE_D0)/(DITROVIE_D0 -10)", 
            "measure": "Non-Worsening of ICIQ + Ditrovie Scales' Scores", 
            "safety_issue": "No", 
            "time_frame": "6 Months (or last measurement if premature ending)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02029027"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Quantitative analyses:\ndifference = ICIQ_M6 - ICIQ_D0\nvariation (%)= 100 x  (ICIQ_M6 - ICIQ_D0)/ICIQ_D0\nQualitative analysis\n* % of patients with a variation % <-10%, between -10% and +10%, >10%", 
                "measure": "ICIQ Score", 
                "safety_issue": "No", 
                "time_frame": "6 Months (or last measurement if premature ending)"
            }, 
            {
                "description": "Quantitative analyses:\ndifference = DITROVIE_M6 - DITROVIE_D0\nvariation (%)= 100 x  (DITROVIE_M6 - DITROVIE_D0)/(DITROVIE_D0 - 10)\nQualitative analysis\n* % of patients with a variation % <-10%, between -10% and +10%, >10%", 
                "measure": "DITROVIE Score", 
                "safety_issue": "No", 
                "time_frame": "6 Months (or least measurement if premature ending)"
            }, 
            {
                "description": "The ICG (clinical global impression) score is the subjective impression of the patient regarding the evolution of her own clinical condition. It will be determined between inclusion and M6 (or the last visit).", 
                "measure": "ICG score", 
                "safety_issue": "No", 
                "time_frame": "6 Months (or last measurement if premature ending)"
            }, 
            {
                "description": "Difference = M6 -D0\nVariation % = 100 x (M6 - D0)/D0", 
                "measure": "SF-12 Health Survey (Medical Outcomes Study Short-Form General Health Survey)", 
                "safety_issue": "No", 
                "time_frame": "6 Months (or last measurement if premature ending)"
            }, 
            {
                "description": "Qualitative analysis:\nimprovement from sub-score > 10 to sub-score < 10\nno change\nworsening from sub-score < 10 to sub-score > 10", 
                "measure": "HAD (Hospital Anxiety and Depression) scale", 
                "safety_issue": "No", 
                "time_frame": "6 months (or last measurement if premature ending)"
            }, 
            {
                "description": "A bladder diary will be filled by the patient for 3 days before the inclusion visit and then for 3 days before the final visit.\nThe following items will be compared between D0 and M6: normal urinary episodes, incontinence episodes and drinks, in number and volume.\nDifference = M6 - D0 Variation % = 100 x (M6-D0)/D0", 
                "measure": "Bladder diary", 
                "safety_issue": "No", 
                "time_frame": "6 Months (or last visit if premature ending)"
            }
        ], 
        "source": "Effik", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Effik", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}